REG - Marlowe PLC - Director/PDMR Shareholding and Total Voting Rights

MarloweAnnouncement

28/03/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240328:nRSb6001Ia&default-theme=true

RNS Number : 6001I  Marlowe PLC  28 March 2024

28 March 2024

 

Marlowe plc

 

Director/PDMR Shareholding

 

Total Voting Rights

 

Marlowe plc ("Marlowe", the "Group" or the "Company"), the UK leader in
business-critical services and software which assure regulatory compliance,
announces that on 27 March 2024, Kevin Quinn, Marlowe's Chairman, exercised
3,913 share options awarded pursuant to the Marlowe 2020 SAYE Scheme at an
exercise price of 460 pence per new ordinary share (the "Exercise").

Following the allotment of the new ordinary shares of 50 pence each in the
capital of the Company ("Ordinary Shares") to satisfy the Exercise, the
Company's issued ordinary share capital will comprise 96,811,631 Ordinary
Shares, none of which are held in treasury. Therefore, the total number of
Ordinary Shares with voting rights in Marlowe following admission will be
96,811,631.

 

The above figure of 96,811,631 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the Company under
the FCA's Disclosure Guidance and Transparency Rules.

 

The notification below, provided in accordance with the UK Market Abuse
Regulation, provides further details.

 

For further information:

 

 Marlowe plc
 Alex Dacre, Chief Executive                     www.marloweplc.com
 Adam Councell, Chief Financial Officer          Tel: +44 (0) 203 813 8498
 Benjamin Tucker, Head of Investor Relations

 Cavendish Capital Markets (Nominated Adviser and Joint Broker)
 Ben Jeynes                                      Tel: +44 (0)20 7220 0500
 George Lawson

 Berenberg (Joint Broker)
 Dan Gee-Summons         Tel: +44 (0)20 3207 7800
 Mark Whitmore

 Stifel (Joint Broker)
 Matthew Blawat          Tel: +44 (0)20 7710 7688
 Francis North

 FTI Consulting
 Nick Hasell             Tel: +44 (0)20 3727 1340
 Alex Le May

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure
regulatory compliance. The company was formed to create sustainable
shareholder value through the acquisition and development of businesses that
provide regulated safety and compliance services and software. It is focused
on compliance software, eLearning, health & safety, employment law &
HR compliance, fire safety & security, water & air hygiene and
occupational health services - all of which are vital to the wellbeing of its
customers operations and are invariably governed by regulation. Marlowe
currently provides software to over 1 million users and services to over 25%
of Britain's commercial premises. The Group provides customers with a single
outsourced, nationwide, provider of a range of regulated compliance and safety
solutions. Our customers can be found in office complexes, high streets &
leisure facilities, manufacturing plants and industrial estates, and include
thousands of SMEs, local authorities, facilities management providers,
multi-site NHS trusts and FTSE 100 companies.

 

 1    Details of the person discharging managerial responsibilities / person closely
      associated
 a)   Name                                                         Kevin Quinn
 2    Reason for the notification
 a)   Position/status                                              Non-Executive Chairman
 b)   Initial notification /Amendment                              Initial notification
 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor
 a)   Name                                                         Marlowe plc
 b)   LEI                                                          213800ZWSR4SBOM6B608
 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary shares of 50 pence each

      Identification code                                          ISIN: GB00BD8SLV43
 b)   Nature of the transaction                                    Exercise of share options under the Marlowe 2020 SAYE Scheme

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     460 pence         3,913

 d)   Aggregated information                                        N/A single transaction

      - Aggregated volume
      - Price
 e)   Date of the transaction                                      27 March 2024

 f)   Place of the transaction                                     Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUBSKRSKUOUAR